Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies by Josée Golay, Alain E. Andrea

Get full text

The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs by Josée Golay, Ronald P. Taylor

Get full text

The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable in vitro activity against chronic lymphocytic leukemia B cells with CD20 antibodies by Josée Golay, Greta Ubiali, Martino Introna

Get full text

Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies by Josée Golay, Alain E. Andrea, Irene Cattaneo

Get full text

Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols by Chiara Capelli, Olga Pedrini, Gisella Cassina, Orietta Spinelli, Silvia Salmoiraghi, Josée Golay, Alessandro Rambaldi, Ursula Giussani, Martino Introna

Get full text

Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1 by Irene Cattaneo, Sylvie Choblet, Rut Valgardsdottir, Muriel Roth, Annamaria Massafra, Marten Beeg, Marco Gobbi, Martine Duonor-Cerutti, Josée Golay

Get full text

FcγRIIIA and FcγRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin’s lymphoma patients treated with sequential CHOP and rituximab by Emanuela Carlotti, Giuseppe A. Palumbo, Elena Oldani, Daniele Tibullo, Silvia Salmoiraghi, Andrea Rossi, Josee Golay, Alessandro Pulsoni, Robin Foà, Alessandro Rambaldi

Get full text

Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b by Katia Todoerti, Valentina Barbui, Olga Pedrini, Marta Lionetti, Gianluca Fossati, Paolo Mascagni, Alessandro Rambaldi, Antonino Neri, Martino Introna, Luigia Lombardi, Josée Golay

Get full text

Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization by Rut Valgardsdottir, Irene Cattaneo, Gavino Napolitano, Annibale Raglio, Orietta Spinelli, Silvia Salmoiraghi, Concetta Castilletti, Daniele Lapa, Maria Rosaria Capobianchi, Claudio Farina, Josee Golay

Get full text

Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab by Silvia Zaninelli, Silvia Panna, Sarah Tettamanti, Giusi Melita, Andrea Doni, Francesca D’Autilia, Rut Valgardsdottir, Elisa Gotti, Alessandro Rambaldi, Josée Golay, Martino Introna

Get full text

Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy by Fabio Da Roit, Patrick J. Engelberts, Ronald P. Taylor, Esther C.W. Breij, Giuseppe Gritti, Alessandro Rambaldi, Martino Introna, Paul W.H.I. Parren, Frank J. Beurskens, Josée Golay

Get full text

Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL by Giuseppe Gritti, Silvia Ferrari, Federico Lussana, Anna Maria Barbui, Francesco Landi, Monica Rondi, Alessandro Putelli, Francesco Ballardini, Giulia Quaresmini, Muriel Paganessi, Chiara Pavoni, Arianna Ghirardi, Elisa Gotti, Chiara Capelli, Josée Golay, Martino Introna, Alessandro Rambaldi

Get full text

The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia. by Alessia Casolaro, Josee Golay, Clara Albanese, Roberta Ceruti, Veronica Patton, Sabrina Cribioli, Alice Pezzoni, Marco Losa, Gemma Texido, Ursula Giussani, Francesco Marchesi, Nadia Amboldi, Barbara Valsasina, Silvia Bungaro, Gianni Cazzaniga, Alessandro Rambaldi, Martino Introna, Enrico Pesenti, Rachele Alzani

Get full text

The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden by Peter Boross, J.H. Marco Jansen, Simone de Haij, Frank J. Beurskens, Cees E. van der Poel, Lisette Bevaart, Maaike Nederend, Josée Golay, Jan G.J. van de Winkel, Paul W.H.I. Parren, Jeanette H.W. Leusen

Get full text

Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study by Martino Introna, Gianmaria Borleri, Elena Conti, Marta Franceschetti, Anna Maria Barbui, Raewyn Broady, Erica Dander, Giuseppe Gaipa, Giovanna D’Amico, Ettore Biagi, Matteo Parma, Enrico M. Pogliani, Orietta Spinelli, Donatella Baronciani, Anna Grassi, Josée Golay, Tiziano Barbui, Andrea Biondi, Alessandro Rambaldi

Get full text

Potency assays and biomarkers for cell-based advanced therapy medicinal products by Chiara Capelli, Carolina Cuofano, Chiara Pavoni, Simona Frigerio, Daniela Lisini, Sara Nava, Michele Quaroni, Valentina Colombo, Francesco Galli, Svetlana Bezukladova, Svetlana Bezukladova, Paola Panina-Bordignon, Paola Panina-Bordignon, Giuseppe Gaipa, Patrizia Comoli, Giulio Cossu, Giulio Cossu, Gianvito Martino, Gianvito Martino, Andrea Biondi, Andrea Biondi, Martino Introna, Josée Golay

Get full text